These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 625789)

  • 21. Properties of commercial factor IX concentrates.
    Coan MH; Fournel MA; Mozen MM
    Ann N Y Acad Sci; 1981; 370():731-46. PubMed ID: 6168231
    [No Abstract]   [Full Text] [Related]  

  • 22. The protective effect of autoprothrombin II - anticoagulant on experimental DIC in animals.
    Emekli NB; Ulutin ON
    Haematologica; 1980 Oct; 65(5):644-51. PubMed ID: 6780422
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical experience of a new monoclonal antibody purified factor IX: half-life, recovery, and safety in patients with hemophilia B.
    Kim HC; McMillan CW; White GC; Bergman GE; Saidi P
    Semin Hematol; 1990 Apr; 27(2 Suppl 2):30-5. PubMed ID: 2094957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Summary report and recommendations of the task force members and consultants.
    Ménachd ; Roberts HR
    Thromb Diath Haemorrh; 1975 Jun; 33(3):645-7. PubMed ID: 1154320
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter: Complications with Christmas factor (factor IX) concentrates.
    Grammens GL; Breckenridge RT
    Ann Intern Med; 1974 May; 80(5):666-7. PubMed ID: 4823822
    [No Abstract]   [Full Text] [Related]  

  • 26. [Principles of the therapy for disseminated intravascular coagulation: current status and new trends].
    Takahashi H
    Nihon Rinsho; 1993 Jan; 51(1):79-86. PubMed ID: 7679452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Various prothrombin complex concentrates and their effect on coagulation and fibrinolysis in vivo.
    Hedner U; Nilsson IM; Bergentz SE
    Thromb Haemost; 1976 Apr; 35(2):386-95. PubMed ID: 989639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular lesions in hemophilia B.
    Steinberg MH; Breiling BJ
    N Engl J Med; 1973 Sep; 289(11):592. PubMed ID: 4723113
    [No Abstract]   [Full Text] [Related]  

  • 29. Disseminated intravascular coagulation: experience in a major cancer center.
    Al-Mondhiry H
    Thromb Diath Haemorrh; 1975 Sep; 34(1):181-93. PubMed ID: 171794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulation factor concentrate in the treatment of the haemorrhagic diathesis of fulminant hepatic failure.
    Gazzard BG; Lewis ML; Ash G; Rizza CR; Bidwell E; Williams R
    Gut; 1974 Dec; 15(12):993-8. PubMed ID: 4448416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of fresh frozen plasma or a concentrate of factor IX as replacement therapy before liver biopsy.
    Gazzard BG; Henderson JM; Williams R
    Gut; 1975 Aug; 16(8):621-5. PubMed ID: 1102399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in the understanding of the pathogenetic pathways of disseminated intravascular coagulation result in more insight in the clinical picture and better management strategies.
    Levi M; de Jonge E; van der Poll T; ten Cate H
    Semin Thromb Hemost; 2001 Dec; 27(6):569-75. PubMed ID: 11740680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of disseminated intravascular coagulation].
    Asakura H
    Rinsho Ketsueki; 1990 Jun; 31(6):756-62. PubMed ID: 2214166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial changes in the coagulation system following clotting factor concentrate infusion.
    Preston FE; Winfield DA; Malia RG; Blackburn EK
    Thromb Diath Haemorrh; 1975 Nov; 34(2):475-82. PubMed ID: 1198408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disseminated intravascular coagulation: a rare entity in burn injury.
    Barret JP; Gomez PA
    Burns; 2005 May; 31(3):354-7. PubMed ID: 15774294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disseminated intravascular coagulation. clinical and pathophysiological mechanisms and manifestations.
    Bick RL; Arun B; Frenkel EP
    Haemostasis; 1999; 29(2-3):111-34. PubMed ID: 10629392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current drug treatment strategies for disseminated intravascular coagulation.
    de Jonge E; Levi M; Stoutenbeek CP; van Deventer SJ
    Drugs; 1998 Jun; 55(6):767-77. PubMed ID: 9617592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel approaches to the management of disseminated intravascular coagulation.
    Levi M; de Jonge E; van der Poll T; ten Cate H
    Crit Care Med; 2000 Sep; 28(9 Suppl):S20-4. PubMed ID: 11007192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disseminated intravascular coagulation.
    Wada H
    Clin Chim Acta; 2004 Jun; 344(1-2):13-21. PubMed ID: 15149867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the thrombogenicity of Scottish factor IX concentrates in dogs.
    Cash JD; Dalton RG; Middleton S; Smith JK
    Thromb Diath Haemorrh; 1975 Jun; 33(3):632-9. PubMed ID: 1154318
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.